Skip to content

Pharma Made Easy

Practical pharmaceutical knowledge for real-world learning.

Tag: regulatory

  • Home
  • regulatory
  • Page 28
pKa, pH, and Buffer Concepts

How pH Affects Drug Solubility, Stability, and Formulation Development

How pH Affects Drug Solubility, Stability, and Formulation Development The Impact of pH on Drug Solubility, Stability, and Formulation Development Understanding the relationship between pH, pKa, and buffer concepts in pharma is crucial for pharmaceutical professionals involved in drug formulation,…
pKa, pH, and Buffer Concepts

pKa, pH, and Buffer Concepts in Pharma: What They Mean and Why They Matter

pKa, pH, and Buffer Concepts in Pharma: What They Mean and Why They Matter Understanding pKa, pH, and Buffer Systems in Pharmaceutical Formulation In the realm of pharmaceuticals, the concepts of pKa, pH, and buffer systems are fundamental to drug…
API Stability and Retest Concepts

When Should an API Be Retested in Pharma? Practical GMP Explanation

When Should an API Be Retested in Pharma? Practical GMP Explanation Understanding API Stability and Retest Concepts in Pharma Active Pharmaceutical Ingredients (APIs) are the cornerstone of pharmaceutical formulations, and ensuring their stability is crucial to maintaining drug efficacy and…
API Stability and Retest Concepts

API Stability and Retest Data in Regulatory Filings: What Must Be Included?

API Stability and Retest Data in Regulatory Filings: What Must Be Included? Understanding API Stability and Retest Data for Regulatory Submissions In the pharmaceutical industry, the stability of Active Pharmaceutical Ingredients (APIs) is a crucial aspect that ensures the safety,…
API Stability and Retest Concepts

How Solid Form, Particle Size, and Residual Solvents Influence API Stability

How Solid Form, Particle Size, and Residual Solvents Influence API Stability Understanding the Impact of Solid Form, Particle Size, and Residual Solvents on API Stability Active Pharmaceutical Ingredients (APIs) are the cornerstone of effective pharmaceuticals. The stability of these compounds…
API Stability and Retest Concepts

API Retest Concepts in Warehousing and Material Management: What QA Should Control

API Retest Concepts in Warehousing and Material Management: What QA Should Control Understanding API Retest Concepts in Warehousing and Material Management for Quality Assurance The pharmaceutical industry relies heavily on the stability and quality of Active Pharmaceutical Ingredients (APIs) to…
API Stability and Retest Concepts

API Stability Trending in Pharma: What Repeated OOT Results Can Indicate

API Stability Trending in Pharma: What Repeated OOT Results Can Indicate Understanding API Stability and Retest Concepts in the Pharmaceutical Industry In the pharmaceutical industry, the stability of Active Pharmaceutical Ingredients (APIs) is crucial for ensuring the quality and efficacy…
API Stability and Retest Concepts

Long-Term vs Accelerated Stability for APIs: What They Show and Why They Matter

Long-Term vs Accelerated Stability for APIs: What They Show and Why They Matter Understanding Long-Term and Accelerated Stability for APIs: Key Insights and Importance In the pharmaceutical industry, ensuring the quality and efficacy of Active Pharmaceutical Ingredients (APIs) is paramount.…
API Stability and Retest Concepts

Retest Date vs Expiry Date in Pharma: Key Differences Explained Clearly

Retest Date vs Expiry Date in Pharma: Key Differences Explained Clearly Understanding the Differences Between Retest Dates and Expiry Dates in Pharmaceuticals In the realm of pharmaceutical manufacturing, particularly in the context of API stability and retest concepts in pharma,…
API Stability and Retest Concepts

How API Stability Affects Formulation Development, Manufacturing, and Release

How API Stability Affects Formulation Development, Manufacturing, and Release The Impact of API Stability on Formulation Development and Manufacturing Processes Active Pharmaceutical Ingredients (APIs) are the cornerstone of pharmaceutical formulations. Understanding the api stability and retest concepts in pharma is…

Posts pagination

Previous 1 … 27 28 29 … 44 Next

Menu

  • Powder Properties and Material Science
    • Density and Volume Properties
    • Flow Properties
    • Particle Size and Distribution
    • Moisture and Hygroscopicity
    • Surface Area and Porosity
    • Solid State Properties
    • Powder Handling and Segregation
    • API-Excipient Compatibility
  • API Development and Manufacturing
  • Preformulation and Drug-Excipient Studies
  • Product Development Fundamentals
  • Solid Oral Dosage Forms – Tablets
  • Solid Oral Dosage Forms – Capsules
  • Liquid Dosage Forms – Oral Liquids
  • Semisolid Dosage Forms
  • Parenteral and Sterile Dosage Forms
  • Ophthalmic, Nasal, and Otic Dosage Forms
  • Pulmonary and Inhalation Products
  • Topical and Transdermal Delivery Systems
  • Modified Release and Advanced Drug Delivery
  • Biologics and Complex Products
  • Analytical Development and Method Science
  • Method Validation, Transfer, and Verification
  • Quality Control Laboratory
  • Microbiology and Sterility Assurance
  • Manufacturing Operations
  • Packaging Development and Packaging Operations
  • Stability Studies
  • Validation and Qualification
  • Quality Assurance and GMP Systems
  • Regulatory Affairs and Submission Concepts
  • Bioavailability, Bioequivalence, and Clinical Performance
  • Excipients and Functional Roles
  • Pharma Engineering and Utilities
  • Cross-Functional Comparison Hub
  • Formulation Development
  • Pharmaceutical R&D
  • Clinical Development and Bioequivalence
  • Medical Devices and Combination Products
Copyright © 2026 Pharma Made Easy Theme: Timely News By Artify Themes.